Article
Identification of three novel mutations in the dihydropyrimidine dehydrogenase gene associated with altered pre-mRNA splicing or protein function.
Biological chemistry - 1 Apr 2005
Van Kuilenburg André B P, Meinsma Rutger, Beke Eva, Bobba Barbara, Boffi Patrizia, Enns Gregory M, Witt David R, Dobritzsch Doreen
Abstract excerpt
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of the pyrimidine bases uracil and thymine, as well as of the widely used chemotherapeutic drug 5-fluorouracil (5FU). Analysis of the DPD gene ( DPYD ) in two patients presenting with complete DPD deficiency and the parents of an affected child showed the presence of three novel mutations, including one splice site...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
